Medscape June 20, 2024
Kathleen Doheny

“My weight has always been kind of an issue,” said Gerald Fernandez, a 33-year-old mortgage broker in Naples, Florida. Over the years, he has sought advice from his physicians but felt unsatisfied with the guidance he has received: “They never gave me a solution, besides ‘Work out more, eat less.'”

Earlier this year, Fernandez found a new clinician who suggested he take a glucagon-like peptide 1 (GLP-1) receptor agonist for weight loss. He said he has lost about 20 lb in the 3 months he has been taking compounded semaglutide. But the medication is not the only difference-maker this time.

When Fernandez’s doctor, Yanet Diaz-Martell, MD, an internist and hospitalist at Physicians Regional Healthcare System in Naples, Florida, discussed his...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Physician, Provider
Follow the Money: T Cell Engineering, Kidney Transplants, Intravascular Imaging Technology, More
Pfizer to pull sickle cell drug from market, shut down trials
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new science
BIOSECURE Act: US to Target Chinese Biotechnology Companies
Drug Topics Top 10: Most Read Stories From September 2024

Share This Article